Search For

TET2 downregulation limits oxidative stress-induced cytotoxicity of high dose ascorbate in dabrafenib-resistant melanoma cells

Mechanistic roles and clinical applications of tertiary lymphoid structures in colorectal cancer drug resistance

An epithelial-mesenchymal transition-related gene signature predicts prognosis, immune infiltration, and drug sensitivity in colorectal cancer

LINC01607 promotes hepatocellular carcinoma progression and ferroptosis-associated therapy resistance with functional involvement of the p62–Keap1–Nrf2 pathway

Unveiling the role of UGT enzymes in chemoresistance: a path to enhanced cancer pharmacotherapy

Overcoming resistance to anti-PD-1/PD-L1 therapy in cancer

Tumor heterogeneity as a driver of drug resistance and its implications for personalized therapy

Novel N-chloroacetyl-2-pyrazoline analogs with 2-naphthyl and ferrocenyl groups: targeting histamine receptor H1 to overcome colorectal cancer drug resistance

Paired single cell analysis reveals chemotherapy resistance in osteosarcoma

Nanomaterial-based strategies overcome PD-1 related intrinsic immune resistance

Multi-omics classification of acute myeloid leukemia guides drug combinations to overcome Venetoclax resistance

Immunotherapy resistance and strategies in malignant pleural mesothelioma